Our Services
Medical Information
Helpful Resources
Published on: 9/15/2026
Tadalafil (Cialis) 5mg has an average half-life of about 17.5 hours, meaning most people fully clear the drug in roughly 3 to 5 days, though noticeable effects typically fade within 36 hours. Because the 5mg dose is often taken daily, it builds to a steady level in your body after about 5 days of consistent use and takes a similar amount of time to wash out after stopping. Clearance can be slower if you have kidney or liver impairment, are older, or take medications such as certain antifungals, HIV protease inhibitors, or antibiotics that slow tadalafil metabolism. Timing also matters for safety, since nitrates, alpha-blockers, and some blood pressure drugs can interact while the medication is still active. There are several important factors that change this timeline, so see below to understand more.
If you are tracking how long Cialis lingers because of side effects like lasting headaches, flushing, back pain, vision changes, or a prolonged erection, guessing can delay care you may need. A free, instant, online symptom check can help you sort ordinary, short-lived effects from signs that warrant prompt medical attention, and it takes only a few minutes. Answering a few questions about your symptoms, medications, and health history gives you clearer language to bring to a pharmacist or clinician, so your next conversation is faster and more useful. Understanding what is happening in your body is the first step to deciding whether to wait, adjust timing with your prescriber, or seek urgent help.
Last reviewed for medical accuracy: 09/15/2026
Cialis (tadalafil) is a popular prescription medication used to treat erectile dysfunction (ED) and, in some cases, benign prostatic hyperplasia (BPH). Understanding how long Cialis stays active in your body—and how quickly it begins to work—can help you plan sexual activity and manage expectations.
• Onset of action
– Most men notice effects 30–60 minutes after taking a 5 mg tablet.
– Some may feel the medication working in as little as 15–20 minutes, especially if taken on an empty stomach.
• Peak concentration
– Blood levels of tadalafil reach their highest point around 2 hours post-dose.
• Factors that influence onset
– Food: A high-fat meal can delay absorption by 1–2 hours.
– Age: Slower gastric emptying in older adults may slightly delay onset.
– Other medications: Antacids containing magnesium or aluminum may reduce absorption if taken at the same time.
• Effective window
– Cialis can remain effective for up to 36 hours after a single 5 mg dose.
– This long “prolonged window” allows for greater spontaneity.
• Residual activity
– Even once you no longer achieve an erection in response to sexual stimulation, low levels of tadalafil may still be measurable in your blood for up to 4 days.
• Tadalafil’s average half-life is approximately 17.5 hours.
• After one half-life, 50% of the drug remains; after two, 25%; after three, 12.5%; and so on.
• Rule of thumb: It takes about 5 half-lives for a drug to be nearly eliminated from your body.
– 17.5 hours × 5 ≈ 87.5 hours (about 3.5 days)
• Rounded up, most healthy adults will have negligible tadalafil levels after 4 days.
Kidney Function
– Impaired renal function can slow clearance.
– People with moderate to severe kidney disease may have prolonged exposure.
Liver Function
– Tadalafil is metabolized by the liver (CYP3A4 pathway).
– Liver impairment can increase blood levels and extend half-life.
Age
– Older adults often have reduced organ function, slightly increasing elimination time.
Dosage and Frequency
– Daily low-dose (2.5–5 mg) regimens lead to steady-state levels.
– With daily use, tadalafil accumulates until a balance between absorption and elimination is reached in about 5 days.
Body Weight and Composition
– Higher body fat percentage can alter volume of distribution, but effects are usually minor.
• Nitrate Medications
– Never combine Cialis with nitrates (e.g., nitroglycerin, isosorbide mononitrate).
– Risk of severe, life-threatening hypotension.
• Alpha-Blockers
– Used for high blood pressure or BPH.
– Can cause a drop in blood pressure when taken with tadalafil; dose adjustments may be needed.
• CYP3A4 Inhibitors/Inducers
– Strong inhibitors (e.g., ketoconazole, ritonavir) can raise tadalafil levels.
– Inducers (e.g., rifampin, carbamazepine) can lower effectiveness.
• Alcohol
– Moderate amounts (1–2 drinks) are generally safe.
– Excessive drinking may increase dizziness or low blood pressure.
A: Yes. Daily use (2.5–5 mg once daily) is FDA-approved for men who anticipate more frequent sexual activity.
A: Most side effects (headache, flushing, nasal congestion) peak within 2–6 hours and usually resolve within 24 hours.
A: Standard drug screens do not test for tadalafil. Specialized assays can detect it, but routine employment or legal tests will not.
Although most side effects are mild, seek urgent care if you experience:
If you ever feel symptoms that could be life-threatening or serious, speak to a doctor right away.
Not sure what’s right for you? Consider a
free, online symptom check, using the doctor approved Ubie Symptom Checker
to explore common symptoms and get guidance on when to seek care.
Cialis 5 mg typically starts working within 30–60 minutes, peaks around 2 hours, and remains in your system for up to 4 days, with an effective window of 36 hours. Factors such as kidney or liver function, age, and other medications can affect these timelines. Always follow your prescriber’s instructions and report concerning symptoms promptly. If you have any doubts—especially about interactions or unexpected side effects—speak to a doctor.
(References)
* Forgue ST, Patterson BE, Bedding AW, Payne CD, Phillips DL, Wrishko RE, Mitchell MI. Tadalafil pharmacokinetics in healthy subjects. Br J Clin Pharmacol. 2006 Mar;61(3):280-8. doi: 10.1111/j.1365-2125.2005.02553.x. PMID: 16487221; PMCID: PMC1885023.
* Drug-induced hearing loss. Prescrire Int. 2014 Dec;23(155):290-4. PMID: 25629145.
* Medeiros VF, Azevedo ÍM, Carvalho MD, Oliveira CN, Egito ES, Medeiros AC. The renoprotective effect of oral Tadalafil pretreatment on ischemia/reperfusion injury in rats. Acta Cir Bras. 2017 Feb;32(2):90-97. doi: 10.1590/s0102-865020170201. PMID: 28300873.
* Vuddanda PR, Montenegro-Nicolini M, Morales JO, Velaga S. Effect of surfactants and drug load on physico-mechanical and dissolution properties of nanocrystalline tadalafil-loaded oral films. Eur J Pharm Sci. 2017 Nov 15;109:372-380. doi: 10.1016/j.ejps.2017.08.019. Epub 2017 Aug 18. PMID: 28823854.
* Victor RG, Sweeney HL, Finkel R, McDonald CM, Byrne B, Eagle M, Goemans N, Vandenborne K, Dubrovsky AL, Topaloglu H, Miceli MC, Furlong P, Landry J, Elashoff R, Cox D, Tadalafil DMD Study Group. A phase 3 randomized placebo-controlled trial of tadalafil for Duchenne muscular dystrophy. Neurology. 2017 Oct 24;89(17):1811-1820. doi: 10.1212/WNL.0000000000004570. Epub 2017 Sep 29. PMID: 28972192; PMCID: PMC5664308.
* Shen X, Chen F, Wang F, Huang P, Luo W. The Effect of Grapefruit Juice on the Pharmacokinetics of Tadalafil in Rats. Biomed Res Int. 2020;2020:1631735. doi: 10.1155/2020/1631735. Epub 2020 Jan 24. PMID: 32047806; PMCID: PMC7003282.
* Abuhassan Q, Khadra I, Pyper K, Augustijns P, Brouwers J, Halbert GW. Structured solubility behaviour in bioequivalent fasted simulated intestinal fluids. Eur J Pharm Biopharm. 2022 Jul;176:108-121. doi: 10.1016/j.ejpb.2022.05.010. Epub 2022 May 20. PMID: 35605926.
* Silva MI, Khadra I, Pyper K, Halbert GW. Structured solubility behaviour in fed simulated intestinal fluids. Eur J Pharm Biopharm. 2023 Dec;193:58-73. doi: 10.1016/j.ejpb.2023.10.017. Epub 2023 Oct 25. PMID: 37890541.
* Elattar S, Basha NR, Salem A, Abdulfattah AY, Taha S, Frishman WH, Aronow WS, Lanier GM. Tadalafil for Treatment of Pulmonary Hypertension: Mechanisms, Evidence, and Emerging Perspectives. Cardiol Rev. 2025 Sep 12. doi: 10.1097/CRD.0000000000001036. Epub 2025 Sep 12. PMID: 40934467.
* Jiang X, Sun F, Shi P, Gu X, Zhao X, Zhang X, Xu Y, Gao X, Ma Y, Fu Y, Cao Y. Bioequivalence Study of Tadalafil Oral Soluble Film and Tadalafil Tablet in Healthy Chinese Volunteers Under Fasting Conditions. Clin Transl Sci. 2025 Dec;18(12):e70440. doi: 10.1111/cts.70440. PMID: 41340316; PMCID: PMC12675823.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.